Target, Wal-Mart Move Pseudoephedrine Behind The Counter
This article was originally published in The Tan Sheet
Target Corporation is the first national retail chain to move all pseudoephedrine-containing products behind pharmacy counters, the firm announced April 18
You may also be interested in...
A wave of decisions from leading OTC drug retailers to place pseudoephedrine solids behind the counter could provide momentum for a federal pseudoephedrine BTC bill
National debate over a meth-control strategy is now focused on a choice between pharmacy-counter sale of pseudoephedrine and a more flexible retail-counter option
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC